1-(Oxan-3-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid

Catalog No. :
ACOPVL432
CAS No. :
1803598-09-5
Molecular Formula :
C10H11F3N2O3
Molecular Weight :
264.20

IUPAC Name:1-(tetrahydro-2H-pyran-3-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid

1-(Oxan-3-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$357.00Login to see priceInquiryInquiry
100mg95%$524.00Login to see priceInquiryInquiry
250mg95%$739.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(Oxan-3-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid
IUPAC Name1-(tetrahydro-2H-pyran-3-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid
MDL No.MFCD28023725
Molecular FormulaC10H11F3N2O3
Molecular Weight264.20
SMILESO=C(C1=C(C(F)(F)F)N(C2COCCC2)N=C1)O
InChI KeyHVZGSWZNJAIDCJ-UHFFFAOYSA-N
Synonym1H-Pyrazole-4-carboxylic acid, 1-(tetrahydro-2H-pyran-3-yl)-5-(trifluoromethyl)-;1-(Oxan-3-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic Acid;1-(Tetrahydro-2H-pyran-3-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid
CAS No.1803598-09-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOPVL432 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOPVL432 route product structure diagram
    ACOPVL4321803598-09-5
Inquiry

2. ACOPVL432 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOPVL432 route product structure diagram
    ACOPVL4321803598-09-5
Inquiry

Comments (0)